INTRODUCTION
============

Several studies have documented a protective role of moderate wine consumption (15.5 to 31 g alcohol/day) in both vascular and nonvascular diseases.[@b1-cln64_5p435]--[@b3-cln64_5p435] Different mechanisms may be responsible for these beneficial effects, including increases in HDL-cholesterol plasma levels,[@b4-cln64_5p435] decreased platelet aggregation,[@b5-cln64_5p435] antioxidant effects,[@b6-cln64_5p435] and restoration of endothelial function by flavonoids.[@b7-cln64_5p435],[@b8-cln64_5p435]

On the other hand, high alcohol intake (\> 31 g alcohol/day) is associated with undesirable consequences, such as elevation of blood pressure[@b9-cln64_5p435],[@b10-cln64_5p435] and activation of the sympathetic system.[@b11-cln64_5p435] Epidemiological studies consistently show a J-shaped relation between alcohol consumption and total mortality.[@b3-cln64_5p435]

We have previously shown that red wine and purple grape juice restore endothelial function in hypercholesterolemic individuals without any additional risk factors.[@b8-cln64_5p435] It is not well known whether this beneficial effect is reproducible in people with other conditions that may be associated with endothelial dysfunction such as arterial hypertension. In fact, the influence of different risk factors on the various properties of red wine has not been fully investigated. Studies comparing the different effects of red wine in populations with different characteristics are lacking.

We have put forward the hypothesis that the effects of red wine on different aspects related to cardiovascular disease may differ according to individual characteristics, specifically whether the subject is hypertensive or hypercholesterolemic.

Hence, the purpose of this study was to compare the effects of 15 days of red wine consumption on the lipid profile, hemodynamic profile, sympathetic activity, and endothelial function of patients with hypercholesterolemia or arterial hypertension and in healthy controls.

MATERIALS AND METHODS
=====================

Subjects and protocol
---------------------

Ten subjects with hypercholesterolemia (HCHOL group), nine with arterial hypertension (AH group), and seven with neither hypercholesterolemia nor arterial hypertension (healthy controls) were enrolled. Arterial hypertension was defined as blood pressure (BP) \>140/90mm Hg, according to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.[@b12-cln64_5p435] Hypercholesterolemia was defined as a plasma LDL-cholesterol \>160 mg/dL. None of the subjects had clinical evidence of any serious disease or condition that alters sympathetic activity such as diabetes mellitus; heart, liver, or renal failure; obesity; smoking; old age (\>65 years); or peripheral neuropathies. They were asked not to ingest products containing caffeine or polyphenols, such as fruit, coffee, tea, and alcoholic beverages other than the wine used in the study, during the 72 hours preceding the protocol examinations. They were encouraged not to change their daily dietary habits otherwise. They were not taking statins, and they were told to stop taking any antihypertensive drugs three weeks before the beginning of the protocol. Any possible harmful effects of medication withdrawal were monitored with periodic blood pressure (BP) measurements and active questioning of the subjects.

Blood collection (after a 12-hour overnight fast), analyses of endothelial function (in the morning) and sympathetic activity (at least 2 hours after lunch) were all conducted on the same day. Individuals were then provided with a supply of red wine (Varietal, Vinícola Aurora, Rio Grande do Sul, Brazil) and instructed to drink 250 mL each night, after a meal, for 15 consecutive days. After this period, evaluation of both endothelial function and sympathetic activity was repeated. Endothelial function was also reassessed 15 days after the discontinuation of red wine consumption (washout period) in 14 subjects.

Written informed consent was obtained from all participants. The ethics committee of the Heart Institute (InCor) and Hospital das Clínicas of the University of São Paulo Medical School approved the protocol.

Blood analysis
--------------

Plasma levels of total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, and glucose were determined by enzymatic methods (Roche Laboratories, Basel, Switzerland).

Microneurography protocol
-------------------------

Muscle sympathetic nerve activity (MSNA) was assessed by direct multiunit recordings of postganglionic sympathetic activity of the fibular nerve. The procedure involved selective insertion of unipolar tungsten microelectrodes into nerve fibers in the muscle, posterior to the fibular head, according to a previously described technique.[@b13-cln64_5p435] Filtered and mean neurograms were recorded on millimetered paper. Muscle sympathetic bursts were identified by visual inspection by a single blinded investigator (F.C.C.) and were expressed as bursts per minute.

After placement of the electrode, the patient rested for 10 minutes to ensure that the BP, heart rate (HR), and MSNA were at basal levels. MSNA was then recorded for 10 minutes. After that, a cold pressor stimulus, consisting of immersion of the hand up to the wrist into ice water for 2 minutes, was initiated. After recording MSNA, this stimulus was followed by another 10-minute rest period to ensure that BP, HR, and MSNA returned to basal conditions. The subjects were then engaged in an isometric exercise, which involved pulling a dynamometer at 30% of the subject's maximum effort for 2 minutes, and MSNA was again determined.

Hemodynamic variables
---------------------

During the microneurography protocol, HR, BP, and electrocardiography (DII lead) were continuously monitored. BP was measured noninvasively, beat-to-beat, using a photoplethysmographic finger device (Portapres, Finapres Medical Systems, The Netherlands). This method is based on a volume-clamp technique, and the mean BP is obtained as the integral of pressure over each beat divided by the corresponding beat interval.[@b14-cln64_5p435],[@b15-cln64_5p435] Measurements were transferred to a computer for calculation of several hemodynamic variables (including cardiac output and systemic vascular resistance) using commercial software (BeatScope 1.1, Finapres Medical Systems, The Netherlands).

Brachial artery reactivity protocol
-----------------------------------

Brachial artery ultrasound studies were performed to assess endothelial function by measuring flow-mediated dilation (FMD) induced by reactive hyperemia as previously described[@b8-cln64_5p435] and according to current guidelines.[@b16-cln64_5p435] Studies were performed after the patient had rested for 10 minutes in a temperature-controlled room (20° to 25°C) using a 7.5-MHz linear array vascular ultrasound transducer and an APOGEE 800 plus ATL ultrasound system (ATL Ultrasound, Bothell, WA, USA).

The left brachial artery was imaged 2 to 15 cm above the elbow and scanned in longitudinal section with the focus zone set to the depth of the near wall. During image acquisition, anatomic landmarks such as fascial planes were noted to help record the same image of the artery throughout the study. Vessel diameter was measured using specific software developed at the Heart Institute (São Paulo, Brazil) that uses a semiautomatic approach to measure artery diameter based on an active contour technique supplemented by multiresolution analysis[@b8-cln64_5p435]. The blinded operator selected a region of interest (0.39 inch in longitudinal diameter) in 6 series of brachial artery images obtained from B-mode ultrasound. The distance between the near and far wall media-adventitia during diastole was obtained for all images, and the average was calculated.

Reactive hyperemia was induced by inflation of a pneumatic BP tourniquet, placed around the forearm, to a systolic BP of 250mm Hg, followed by deflation after 5 minutes. FMD was calculated as the ratio of the brachial artery diameter after reactive hyperemia to the baseline diameter, expressed as percent variation.

Endothelium-independent vasodilation was assessed by administration of sublingual isosorbide dinitrate (5 mg) and calculated in an analogous fashion. The average of two measurements was taken.

Statistical analysis
--------------------

Continuous variables were reported as mean ± standard deviation (SD), unless otherwise noted. Data were compared using the paired Student's *t* test or analysis of variance (ANOVA) with repeated measurements, and post hoc analyses were performed to determine differences between two groups and/or two moments (for instance, after vs. before red wine intake).

Correlation analyses were also performed to assess interdependence between changes in different variables after red wine intake.

The level of significance was taken to be p \< 0.05 for all analyses.

RESULTS
=======

Clinical and laboratory data
----------------------------

Table [1](#t1-cln64_5p435){ref-type="table"} summarizes the clinical and laboratory characteristics of the three groups before and after red wine consumption. Groups were comparable in terms of gender and age distributions. As expected, the HCHOL group exhibited higher plasma levels of total cholesterol and LDL-cholesterol compared with the AH and control groups and higher plasma concentrations of triglycerides compared with controls. Both the AH and HCHOL groups exhibited higher glucose levels than the controls, and the hypertensive individuals recorded a higher average body mass index than the controls.

When all patients were grouped together, red wine intake significantly increased plasma concentrations of triglycerides (21%, p \<0.01) and glucose (3%, p = 0.03). A significant elevation in HDL-cholesterol plasma levels after red wine intake was observed only in the healthy controls (14%, p = 0.02).

Hemodynamic measurements and sympathetic activity
-------------------------------------------------

### Resting condition

Before red wine intake, systolic BP was significantly higher in the AH group compared with controls. Also, diastolic BP was nonsignificantly higher in the AH group than in the other groups, and, as expected, mean BP was significantly higher in the AH group than in the other groups (Table [2](#t2-cln64_5p435){ref-type="table"}). This finding was not associated with significant differences in resting MSNA among the three groups (Table [3](#t3-cln64_5p435){ref-type="table"}).

Although red wine markedly increased resting MSNA in the HCHOL and AH groups, the variation in healthy controls was minimal (Table [3](#t3-cln64_5p435){ref-type="table"}). Indeed, after red wine intake, the peripheral sympathetic system was significantly more activated in the hypertensive and hypercholesterolemic individuals than in the healthy controls (Table [3](#t3-cln64_5p435){ref-type="table"}).

In contrast with this sharp increase in sympathetic activity in the HCHOL and AH groups, the hemodynamic consequences of red wine were mild, non-significantly more prominent in healthy subjects (Table [2](#t2-cln64_5p435){ref-type="table"}), and characterized by a high interindividual variability, especially in the HCHOL and AH groups.

Grouping all the patients together, red wine reduced systolic BP from 143 ± 13 mmHg to 138 ± 13 mmHg (p = 0.01), diastolic BP from 84 ± 9 mmHg to 78 ± 8 mmHg (p \<0.01), and mean BP from 108 ± 11 mmHg to 101 ± 10 mmHg (p \<0.01). This effect was likely driven by a fall in systemic vascular resistance, which decreased 7% across all patients (p = 0.05 vs. before red wine), 1% in the HCHOL group, 8% in the AH group, and 17% in the controls (p = ns for comparison among groups). No significant change was found in the variation of the cardiac output or HR after red wine consumption in any group (Table [2](#t2-cln64_5p435){ref-type="table"}).

No correlation was detected between the variation in resting MSNA (after vs. before red wine) and either the change in mean BP or systemic vascular resistance.

### Effects of cold stimulus

As expected, cold stimulus increased MSNA (26% before, 36% after red wine intake, p ≤0.01 vs. resting condition, across all patients).

Before the red wine intake, cold stimulus caused systolic and diastolic BP to increase 21 ± 10% and 19 ± 10%, respectively (p ≤0.01 vs. resting condition, considering all patients). After consuming red wine, the corresponding values were 23 ± 10% and 21 ± 9% (p ≤0.01 vs. resting condition, across all patients). There was no significant difference among the three groups in terms of blood pressure variation with the cold stimulus either before or after red wine intake.

Although it did not attain statistical significance, the increase in systemic vascular resistance with the cold stimulus was less pronounced after vs. before red wine, especially in healthy subjects. In the HCHOL group, the increase was 20% before and 12% after red wine; in the AH group, the numbers were 46% and 40%, respectively; in controls, 22% and 7%, respectively.

### Effects of isometric exercise

As expected, isometric exercise increased MSNA (31% before, 26% after red wine intake, p ≤0.02 vs. resting condition, across all patients). The effects of isometric exercise on hemodynamic measurements were more modest than those reported for the cold test. Before red wine intake, grouping all the patients together, both systolic and diastolic BP increased 7% (p \<0.01), and systolic vascular resistance increased 6% (p = 0.07). The magnitude of these isometric exercise-induced variations was unchanged by red wine. In addition, no significant difference was observed among the groups.

Brachial artery reactivity
--------------------------

Before red wine intake, FMD was nonsignificantly lower in the HCHOL and AH groups compared to the controls (Figure [1](#f1-cln64_5p435){ref-type="fig"}). Red wine restored FMD in the HCHOL group, but not in the AH group. Endothelium-independent vasodilation was nonsignificantly impaired in the AH group compared with the HCHOL group and controls, both before or after red wine consumption.

We also sought to evaluate the subset of 14 individuals who performed the brachial artery reactivity test after a washout period. In five HCHOL subjects, the FMD was 6.9 ± 12.3% at the beginning of the study, increased to 14.7 ± 2.8% after red wine, and fell to −0.4 ± 7.4% after red wine washout, indicating, on average, an absence of FMD following red wine withdrawal. In seven hypertensive patients, FMD was 4.7 ± 1.5%, 5.2 ± 5.7%, and 3.6 ± 2.2 % before red wine, after red wine, and after washout, respectively. In two healthy subjects, the respective dilations were 13.1 ± 1.7%, 15.8 ± 1.9%, and 14.8 ± 6.1%.

There was no correlation between changes in either MSNA or systemic vascular resistance (after vs. before red wine intake) and variation in FMD.

DISCUSSION
==========

Numerous cross-sectional, observational, and controlled studies reveal a range of red wine effects on different aspects related to cardiovascular disease.[@b3-cln64_5p435],[@b17-cln64_5p435] Other studies show the relations of essential hypertension and coronary disease with genetic background,[@b18-cln64_5p435] capillary density,[@b19-cln64_5p435] and blood levels of cholesterol.[@b20-cln64_5p435],[@b21-cln64_5p435] Most of these studies have addressed one or a few outcomes, and not several at the same time, as in the current investigation. Moreover, most of the previous controlled trials have enrolled only healthy people[@b17-cln64_5p435] and have not compared different populations simultaneously.

Our objectives were to compare the metabolic, hemodynamic, autonomic, and endothelial responses to red wine in subjects with hypercholesterolemia or arterial hypertension, or in healthy controls with neither of these risk factors. Several major findings are contributed by this study: (1) red wine increased plasma HDL-cholesterol levels only in the control group; (2) red wine slightly decreased mean BP in all groups, which was associated with a borderline-significant fall in systemic vascular resistance; (3) red wine caused a significant increase in sympathetic activity in the HCHOL and AH groups but not in controls; and (4) red wine restored FMD in the HCHOL group but not in the AH group.

Metabolic changes
-----------------

Several studies have documented the effects of alcoholic beverages on lipid metabolism.[@b17-cln64_5p435] In particular, the HDL-cholesterol-raising property of red wine seems to be primarily dependent on the alcoholic content, given that one head-to-head comparison shows that red wine, but not red grape extract, increases blood HDL-cholesterol concentrations.[@b22-cln64_5p435]

In a meta-analysis of studies evaluating different ethanol-containing drinks in mostly healthy individuals, Rimm et al.[@b17-cln64_5p435] reported that 30 g of ethanol per day increases the plasma concentration of HDL-cholesterol by 4 mg/dL and of triglycerides by 6 mg/dL. Thus, the increase in triglyceride levels that we observed is consistent, although more than 3-fold higher, than that reported by Rimm et al.[@b17-cln64_5p435]

The present study revealed that the increase in plasma HDL-cholesterol concentration was restricted to healthy subjects. In a previous investigation, we also observed no increase in HDL-cholesterol levels after 14 days of red wine ingestion in individuals with a high baseline plasma concentration of total cholesterol.[@b8-cln64_5p435] One possible explanation for this finding is related to individuals being overweight or obese. In our cohort, healthy controls were thinner than the hypercholesterolemic or hypertensive patients. Interestingly, Hagiage et al.[@b23-cln64_5p435] demonstrated that wine (30 g ethanol for 14 days) increases apolipoprotein A1 and decreases cholesteryl ester transfer protein activity in normoponderal but not in obese subjects, suggesting that obesity-associated abnormalities impair the effects of wine on HDL metabolism.

The very mild elevation in plasma glucose levels after red wine intake and the short-term nature of this study do not allow speculation as to the possible undesirable consequences of long-term alcohol intake on glucose metabolism. However, available data from the literature point in the opposite direction: population studies show that low-to-moderate regular alcohol intake decreases insulinemia and improves insulin sensitivity.[@b24-cln64_5p435],[@b25-cln64_5p435] In addition, alcohol consumption was recently inversely associated with the risk of type 2 diabetes in women in a case-control study.[@b26-cln64_5p435]

Hemodynamic measurements
------------------------

Chronic heavy alcohol ingestion is consistently associated with hypertension.[@b3-cln64_5p435] Although more controversial, moderate alcohol/red wine consumption is also believed to raise blood pressure, although an acute, transitory fall is reported to happen in the first hours after alcohol ingestion.[@b9-cln64_5p435],[@b10-cln64_5p435],[@b17-cln64_5p435]

Our study does not support the belief that moderate, short-term red wine consumption increases BP. Despite a high interindividual variability in our hemodynamic data that prevents definitive conclusions, red wine intake decreased the average BP in association with a quasi-significant fall in systemic vascular resistance. Interestingly, this decrease in BP was not observed in our previous investigation, using a very similar protocol.[@b8-cln64_5p435] Differences in the type of wine used and the manner of measuring BP (standard pneumatic method in the forearm vs. plethysmographic finger device) may explain these contrasting results.

Importantly, the decrease in systemic vascular resistance cannot be attributed to changes in either sympathetic activity or endothelial function, suggesting a direct vasodilatory action of red wine. The less-pronounced elevation in systemic vascular resistance with the cold test after red wine consumption is also consistent with a vasodilatory property of red wine.

It is interesting to note that red wine increased sympathetic outflow only in the HCHOL and AH groups, whereas hemodynamic changes (decreases in BP and systemic vascular resistance) were nonsignificantly less expressive in these groups, as compared to controls. In addition, the attenuating effect of red wine on the increase in systemic vascular resistance with cold stimulus was more evident in healthy individuals. Although we found no correlation among variations (after vs. before red wine) in terms of MSNA, systemic vascular resistance, and FMD, these observations allow us to suggest that red wine decreases systemic vascular resistance and BP through a direct vasodilatory effect, but that activation of the sympathetic system (possibly by alcohol) blunts these hemodynamic effects.

Sympathetic activity
--------------------

Previous studies[@b27-cln64_5p435],[@b28-cln64_5p435] have shown that acute alcohol or red wine ingestion increases sympathetic activity in healthy volunteers, in disagreement with the lack of increase in MSNA in our control group. It is possible that this discrepancy reflects the longer duration of and more moderate nature of alcohol intake in our study.

The reason why red wine increased MSNA in the HCHOL and AH groups but not in controls is not clear. Although speculative, it may be true that individuals with lipid disorders and those with hypertension share some abnormality that is responsible for the different effects of ethanol or red wine on autonomic activity, compared with normal individuals. A very reasonable candidate is the baroreflex dysfunction, which is known to be a feature of arterial hypertension and other conditions closely related to lipid abnormalities such as coronary artery disease, diabetes mellitus, obesity, and metabolic syndrome.[@b29-cln64_5p435] Accordingly, baroreceptor impairment may be implicated in some ethanol effects.[@b30-cln64_5p435] Therefore, the baroreflex dysfunction might be the link between red wine intake and increased MSNA in the HCHOL and AH groups, but not in healthy persons.

Endothelial function
--------------------

The increase in FMD after red wine consumption in hypercholesterolemic subjects confirms our previous findings[@b8-cln64_5p435] and supports the results of other studies that show acute benefits of wine or de-alcoholized red wine on the endothelium in patients with coronary artery disease.[@b31-cln64_5p435],[@b32-cln64_5p435] In the present study, in particular, the obvious fall in FMD after the washout period (this actually suggests a rebound effect) clearly supports a beneficial role of red wine components as they impact the endothelium in this population. This effect is most likely related to higher nitric oxide bioavailability.[@b33-cln64_5p435], [@b34-cln64_5p435]

The lack of improvement in endothelial function in our hypertensive patients should be confirmed with further studies. Assuming endothelial dysfunction is an accepted marker of early atherosclerosis and has prognostic relevance, [@b35-cln64_5p435] this finding has important clinical implications. We note, however, that endothelium-independent vasodilation was nonsignificantly lower in the AH group, which might have influenced the results of the reactive hyperemia.

Although our study failed to determine why the endothelial response to red wine was inconsistent between individuals with hypercholesterolemia or hypertension, we suggest that different mechanisms may account for endothelial dysfunction under such conditions. In support of this possibility, two studies from the same group have demonstrated that, in patients with essential hypertension, endothelium-dependent vasodilation in response to bradykinin is impaired. This contrasts with a preserved response to bradykinin in hypercholesterolemic subjects.[@b36-cln64_5p435],[@b37-cln64_5p435]

Limitations
-----------

Our sample size may not have been sufficiently large to detect certain differences in the effects of red wine among the groups. We emphasize that this study evaluated the effects of short-term red wine intake, and our conclusions should not be extrapolated to longer-term ingestion scenarios. Endothelial function was analyzed using only one method, as was sympathetic activity. Mechanistic investigations, such as those involved in baroreflex dysfunction, were not performed. The lack of measurement of concentrations of resveratrol, catechin, or quercetin in plasma or urine does not allow us to reach firm conclusions regarding the effects of flavonoids in this study.

CONCLUSIONS
===========

This study highlights the existence of significant variability in the effects of red wine on different patient groups. Elevation in HDL-cholesterol levels was noted only in healthy subjects, but not in those with arterial hypertension or high total cholesterol levels. Hemodynamic consequences of red wine intake were somewhat variable among subjects across all groups; on average, red wine decreased mean BP, probably due to a direct vasodilatory action. Red wine activated the sympathetic system in individuals with hypercholesterolemia or arterial hypertension, but not in healthy controls. In terms of improving endothelial function, individuals with hypertension do not benefit from red wine as hypercholesterolemic subjects do.

Further investigations involving larger samples are required to confirm and understand the mechanisms involved in these findings and, consequently, to provide therapeutic implications. So far, the results reinforce the need for us to consider patient characteristics when evaluating the medical properties of red wine.

This study was supported by FAPESP - The State of São Paulo Research Foundation (number 03/09084-0) -- São Paulo-SP, Brazil.

![Brachial artery flow-mediated (A) and nitroglycerin-mediated (B) dilation before and after red wine intake. Values are shown as means ± standard errors. AH: arterial hypertension; HCHOL: hypercholesterolemia. \* p = 0.01 before vs. after red wine in the HCHOL group](cln64_5p435f1){#f1-cln64_5p435}

###### 

Clinical and laboratory data of patients before and after red wine intake

                              Hypercholesterolemia (n=10)                           Arterial hypertension (n=9)   Control (n=7)                                                                                                                                                     
  --------------------------- ----------------------------------------------------- ----------------------------- ------------------------------------------------------- ----------------------------------------------------- --------------------------------------------------- ----------------------------------------------------
  Sex (men/women)             7/3                                                   7/2                           5/2                                                                                                                                                               
  Age (years)                 43.2 ± 6.9                                            45.1 ± 7.4                    37.3 ± 7.2                                                                                                                                                        
  BMI (kg/m^2^)               25.6 ± 2.9                                            25.8 ± 3.0                    27.9 ± 1.9[d](#tfn5-cln64_5p435){ref-type="table-fn"}   28.1 ± 1.9                                            24.5 ± 2.9                                          24.4 ± 2.7
  Total cholesterol (mg/dL)   259 ± 19[a](#tfn2-cln64_5p435){ref-type="table-fn"}   242 ± 37                      199 ± 45                                                192 ± 51                                              172 ± 23                                            194 ± 38
  LDL-cholesterol (mg/dL)     181 ± 17[a](#tfn2-cln64_5p435){ref-type="table-fn"}   164 ± 31                      131 ± 38                                                117 ± 39                                              106 ± 15                                            119 ± 27
  HDL-cholesterol (mg/dL)     53 ± 9                                                49 ± 9                        47 ± 10                                                 48 ± 10                                               52 ± 12                                             59 ± 16[e](#tfn6-cln64_5p435){ref-type="table-fn"}
  Triglycerides (mg/dL)       126 ± 46[b](#tfn3-cln64_5p435){ref-type="table-fn"}   139 ± 66                      100 ± 36                                                131 ± 51[e](#tfn6-cln64_5p435){ref-type="table-fn"}   70 ± 24                                             81 ± 30
  Glucose (mg/dL)             97 ± 9                                                99 ± 10                       97 ± 8                                                  101 ± 9                                               88 ± 7[c](#tfn4-cln64_5p435){ref-type="table-fn"}   91 ± 5

BMI: body mass index; Data are reported as mean ± SD;

p \<0.01 vs. AH or control before red wine;

p = 0.04 vs. control before red wine;

p ≤0.04 vs. AH or HCHOL before red wine;

p = 0.03 vs. control before red wine;

p = 0.02 vs. before red wine

###### 

Hemodynamic data at rest, before and after red wine intake

                                                 Hypercholesterolemia (n=10)   Arterial hypertension (n=9)   Control (n=7)                                                                                                            
  ---------------------------------------------- ----------------------------- ----------------------------- ---------------------------------------------------- ----------------------------------------------------- ------------- ----------------------------------------------------
  Heart rate (bpm)                               68 ± 9                        68 ± 11                       76 ± 14                                              75 ± 10                                               69 ± 13       71 ± 6
  Systolic BP (mmHg)                             141 ± 15                      135 ± 12                      153 ± 8[a](#tfn8-cln64_5p435){ref-type="table-fn"}   149 ± 8[c](#tfn10-cln64_5p435){ref-type="table-fn"}   134 ± 6       129 ± 8
  Diastolic BP (mmHg)                            80 ± 11                       75 ± 7                        89 ± 5                                               85 ± 6[c](#tfn10-cln64_5p435){ref-type="table-fn"}    83 ± 7        73 ± 7 e
  Mean BP (mmHg)                                 104 ± 13                      97 ± 8                        116 ± 6[b](#tfn9-cln64_5p435){ref-type="table-fn"}   111 ± 6[d](#tfn11-cln64_5p435){ref-type="table-fn"}   103 ± 9       94 ± 6[e](#tfn12-cln64_5p435){ref-type="table-fn"}
  Cardiac output (L/min)                         6.32 ± 1.25                   6.14 ± 1.08                   6.19 ± 0.98                                          6.55 ± 1.26                                           5.70 ± 1.37   6.46 ± 1.27
  Systemic vascular resistance (dyne.s.cm^−5^)   1037 ± 291                    981 ± 170                     1208 ± 283                                           1072 ± 283                                            1158 ± 386    919 ± 245

BP: blood pressure; Data are reported as mean ± SD;

p = 0.01 vs. control before red wine;

p \<0.01 vs. HCHOL or control before red wine;

p ≤0.03 vs. control after red wine;

p \<0.01 vs. HCHOL or control after red wine;

p ≤0.03 vs. before red wine

###### 

Muscle sympathetic nerve activity (bursts/min) before and after red wine intake

                       Hypercholesterolemia (n=10)   Arterial hypertension (n=9)                               Control (n=7)                                                                          
  -------------------- ----------------------------- --------------------------------------------------------- --------------- --------------------------------------------------------- ------------ --------------------------------------------------------
  Rest                 27.0 ± 6.8                    49.9 ± 5.5[a](#tfn14-cln64_5p435){ref-type="table-fn"}    30.0 ± 8.0      42.7 ± 9.6                                                26.6 ± 7.1   26.9 ± 8.8[b](#tfn15-cln64_5p435){ref-type="table-fn"}
  Cold stimulus        31.2 ± 6.5                    62.9 ± 9.2[a](#tfn14-cln64_5p435){ref-type="table-fn"}    36.9 ± 11.1     58.1 ± 11.9[a](#tfn14-cln64_5p435){ref-type="table-fn"}   33.9 ± 5.0   37.4 ± 6.6[c](#tfn16-cln64_5p435){ref-type="table-fn"}
  Isometric exercise   34.4 ± 9.1                    55.8 ± 10.9[a](#tfn14-cln64_5p435){ref-type="table-fn"}   36.1 ± 15.9     51.2 ± 13.6[a](#tfn14-cln64_5p435){ref-type="table-fn"}   31.1 ± 5.8   37.4 ± 7.4[d](#tfn17-cln64_5p435){ref-type="table-fn"}

Data are reported as mean ± SD;

p ≤ 0.02 vs. before red wine;

p ≤ 0.02 vs. HCHOL or AH at rest, after red wine;

p \< 0.01 vs. HCHOL or AH at cold test, after red wine;

p \< 0.01 vs. HCHOL at isometric exercise, after red wine
